BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15171620)

  • 1. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors.
    Filion RJ; Popel AS
    Ann Biomed Eng; 2004 May; 32(5):645-63. PubMed ID: 15171620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced coupling versus receptor pre-association: cellular automaton simulations of FGF-2 binding.
    Gopalakrishnan M; Forsten-Williams K; Täuber UC
    J Theor Biol; 2004 Mar; 227(2):239-51. PubMed ID: 14990388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of receptor clustering on ligand dissociation kinetics: theory and simulations.
    Gopalakrishnan M; Forsten-Williams K; Nugent MA; Täuber UC
    Biophys J; 2005 Dec; 89(6):3686-700. PubMed ID: 16150967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase.
    Kan M; Wu X; Wang F; McKeehan WL
    J Biol Chem; 1999 May; 274(22):15947-52. PubMed ID: 10336501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational model of FGF-2 binding and HSPG regulation under flow.
    Shen W; Zhang C; Fannon MW; Forsten-Williams K; Zhang J
    IEEE Trans Biomed Eng; 2009 Sep; 56(9):2147-55. PubMed ID: 19272950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor-2 Binding to Heparan Sulfate Proteoglycans Varies with Shear Stress in Flow-Adapted Cells.
    Garcia J; Patel N; Basehore S; Clyne AM
    Ann Biomed Eng; 2019 Apr; 47(4):1078-1093. PubMed ID: 30689065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanisms for the regulation of growth factor binding by heparin.
    Forsten KE; Fannon M; Nugent MA
    J Theor Biol; 2000 Jul; 205(2):215-30. PubMed ID: 10873433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate proteoglycans as transducers of FGF-2 signalling.
    Quarto N; Amalric F
    J Cell Sci; 1994 Nov; 107 ( Pt 11)():3201-12. PubMed ID: 7699017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences between the effects of heparin and glypican-1 on the bioactivity of acidic fibroblast growth factor and the keratinocyte growth factor.
    Berman B; Ostrovsky O; Shlissel M; Lang T; Regan D; Vlodavsky I; Ishai-Michaeli R; Ron D
    J Biol Chem; 1999 Dec; 274(51):36132-8. PubMed ID: 10593896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow.
    Patel NS; Reisig KV; Clyne AM
    Ann Biomed Eng; 2013 Jan; 41(1):154-71. PubMed ID: 22825797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
    Mundhenke C; Meyer K; Drew S; Friedl A
    Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
    Zhang F; Zhang Z; Lin X; Beenken A; Eliseenkova AV; Mohammadi M; Linhardt RJ
    Biochemistry; 2009 Sep; 48(35):8379-86. PubMed ID: 19591432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2.
    Zehe C; Engling A; Wegehingel S; Schäfer T; Nickel W
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15479-84. PubMed ID: 17030799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex.
    McKeehan WL; Wu X; Kan M
    J Biol Chem; 1999 Jul; 274(31):21511-4. PubMed ID: 10419453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.